BUSINESS● LOW3h ago · Oct 19, 2026, 4:43 PM
Roche and Hansoh ink cancer drug deal potentially worth more than $14B
Seeking Alpha Tech · global
Roche and Hansoh have finalized a cancer drug deal that could be valued at over $14 billion. This signifies a major collaboration in the pharmaceutical industry for cancer treatment development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS19m agoAnthropic nearing second $45B deal with Nscale for compute power: reportSeeking Alpha TechBUSINESS24m agoLiveRamp gains after FTC approves $2.5B sale to Publicis with conditionsSeeking Alpha Tech